Literature DB >> 22837018

Periodic fever as the manifestation of primary Sjogren's syndrome: a case report and literature review.

Hui-Ching Wang1, Ko Chang, Chun-Yu Lin, Yen-Hsu Chen, Po-Liang Lu.   

Abstract

A 56-year-old male had periodic fever for 5 years and suffered from auditory hallucination and hearing impairment for 3 years. Xerostomia, xerophthalmia, elevated anti-SSA/Ro tilter, positive Schirmer's test, and lymphocyte infiltrate of mucoserous gland in lip biopsy of this case confirmed the diagnosis of primary Sjogren's syndrome (pSS). We review literature for fever and neuropsychiatric involvement in pSS case series. Though fever is present in 6-41 % pSS cases, periodic fever has not been reported. Auditory hallucination was rare in cases with pSS. The literature review alerts clinicians that fever and neurological manifestations were not uncommon in pSS cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22837018     DOI: 10.1007/s10067-012-2039-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  CNS Sjögren's syndrome: an underrecognized and underappreciated neuropsychiatric disorder.

Authors:  P D Cox; R E Hales
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

2.  Central nervous system involvement in Sjogren's syndrome.

Authors:  F C Soliotis; C P Mavragani; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

3.  Neurological manifestations of primary Sjögren's syndrome in Japanese patients.

Authors:  Y Tajima; Y Mito; Y Owada; E Tsukishima; F Moriwaka; K Tashiro
Journal:  Intern Med       Date:  1997-10       Impact factor: 1.271

4.  Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene.

Authors:  Koji Higai; Noriko Miyazaki; Yutaro Azuma; Kojiro Matsumoto
Journal:  FEBS Lett       Date:  2006-10-12       Impact factor: 4.124

5.  Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

Authors:  B K Davidson; C A Kelly; I D Griffiths
Journal:  Rheumatology (Oxford)       Date:  1999-03       Impact factor: 7.580

6.  Investigation of glycosylating properties of 1-deoxy-1-ethoxysulfonyl-hept-2-ulopyranosyl derivatives. Synthesis of a new sulfonic acid mimetic of the sialyl Lewis X tetrasaccharide.

Authors:  Magdolna Csávás; Gábor Májer; Mihály Herczeg; Judit Remenyik; László Lázár; Attila Mándi; Anikó Borbás; Sándor Antus
Journal:  Carbohydr Res       Date:  2011-04-24       Impact factor: 2.104

7.  The treatable dementia of Sjögren's syndrome.

Authors:  R J Caselli; B W Scheithauer; C A Bowles; M R Trenerry; F B Meyer; J S Smigielski; M Rodriguez
Journal:  Ann Neurol       Date:  1991-07       Impact factor: 10.422

8.  The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells.

Authors:  Junya Mitoma; Tatsuo Miyazaki; Mark Sutton-Smith; Misa Suzuki; Hideo Saito; Jiunn-Chern Yeh; Takehiro Kawano; Ole Hindsgaul; Peter H Seeberger; Maria Panico; Stuart M Haslam; Howard R Morris; Richard D Cummings; Anne Dell; Minoru Fukuda
Journal:  Glycoconj J       Date:  2008-12-17       Impact factor: 2.916

9.  PSGL-1 from the murine leukocytic cell line WEHI-3 is enriched for core 2-based O-glycans with sialyl Lewis x antigen.

Authors:  Ziad S Kawar; Thomas K Johnson; Suvi Natunen; John B Lowe; Richard D Cummings
Journal:  Glycobiology       Date:  2008-02-29       Impact factor: 4.313

10.  Synthesis of a sialic acid alpha(2-3) galactose building block and its use in a linear synthesis of sialyl Lewis X.

Authors:  Shinya Hanashima; Bastien Castagner; Davide Esposito; Toshiki Nokami; Peter H Seeberger
Journal:  Org Lett       Date:  2007-04-06       Impact factor: 6.005

View more
  1 in total

1.  Fever of unknown origin (FUO) in children: a single-centre experience from Beijing, China.

Authors:  Bing Hu; Tian-Ming Chen; Shu-Ping Liu; Hui-Li Hu; Ling-Yun Guo; He-Ying Chen; Shao-Ying Li; Gang Liu
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.